Mark Germain
About Mark Germain
Mark Germain is a co-founder and board member with extensive experience in various companies, including ChromaDex and Scinai Immunotherapeutics. He has held leadership roles in organizations across the United States and Israel since the early 2000s.
Work at ChromaDex
Mark Germain has been a co-founder and member of the Board of Directors at ChromaDex since its inception in February 2000. He served as Co-Chairman from February 2000 until May 2010. His involvement in the company spans over 24 years, during which he has contributed to its strategic direction and growth. ChromaDex is based in Irvine, California, and focuses on developing and commercializing innovative dietary supplements and ingredients.
Experience at Pluristem Therapeutics
Mark Germain served on the Board of Directors at Pluristem Therapeutics from 2007 to 2022, including a term as Co-Chairman from 2007 to 2009. His tenure at Pluristem, a company based in Israel, lasted for 15 years. During this time, he played a role in overseeing the company's strategic initiatives and advancements in cell therapy.
Current Role at Scinai Immunotherapeutics Ltd.
Since 2018, Mark Germain has held the position of Chairman of the Board of Directors at Scinai Immunotherapeutics Ltd. He previously served as Vice Chairman from June 2018 to September 2019. Scinai Immunotherapeutics operates in Israel and focuses on developing innovative immunotherapy solutions.
Leadership at HerronTech
Mark Germain has been the Chairman of the Board of Directors at HerronTech since 2017. The company is located in the Austin, Texas Area. In this role, he oversees the board's activities and contributes to the company's strategic vision and operational oversight.
Education and Expertise
Mark Germain studied at New York University School of Law, where he earned his Juris Doctor (JD) degree. His legal education has provided him with a strong foundation in law, which he applies in his various roles across multiple organizations.
Role at The Aentib Group
Since 2014, Mark Germain has served as Managing Director at The Aentib Group, which operates in both New York City and Paris. In this capacity, he is responsible for guiding the company's strategic initiatives and managing its operations.
Advisory Role at Lunit
Mark Germain has been an advisor and member of the Board of Directors at Lunit USA since 2021. Lunit is a company based in Seoul, South Korea, specializing in AI-powered medical solutions. His involvement supports the company's mission to enhance healthcare through innovative technology.